Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of Florida
Massachusetts General Hospital
M.D. Anderson Cancer Center
Swiss Cancer Institute
Sarcoma Alliance for Research through Collaboration
Translational Oncology Research International
National Cancer Institute (NCI)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)